NeuroSpectrum™360: Research and Clinical References

NeuroSpectrum™360: Research and Clinical References

Clinical Reference Guide

NeuroSpectrum™360 : For Healthcare Providers

Download PDF

Research Summary

Over 30 independent medical journal publications back the NeuroSpectrum™360 formulation.†

Download PDF

Improve Patient Outcomes With Micronutrient Therapy

Patients who are recovering from traumatic brain injury or who are suffering from debilitating mood disorders have been shown to benefit from clinical micronutrient therapy.*

Dr. Julia Rucklidge, who has done extensive research on David Hardy’s NutraTek™ enhanced formulations†
shares some of her findings on the TEDx stage in Christchurch, New Zealand:

Many healthcare professionals are recommending NeuroSpectrum™360 to patients because of the overwhelming clinical outcomes backing NutraTek™ enhanced formulations.†

Medical Journal Publications

This broad-spectrum approach has been extensively researched and has been shown to be incredibly powerful.

NeuroSpectrum™360 is part of a family of products co-formulated by David Hardy of Hardy Nutritionals® and powered by NutraTek™ Technology.

The published independent research on David Hardy’s formulations are below.†